including saline and dialysis solutions, across the United States. The company also said the U.S. Food and Drug Administration had authorized temporary importation from two other Baxter ...

Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related ...

The Food and Drug Administration said Tuesday that two doses of Baxter's dextrose solutions for low blood sugar and a saline solution are in shortage. In a letter to healthcare leaders posted ...

Baxter enjoys such dominance because of low prices for IV solutions combined with high entry cost because of sterility requirements. Baxter has been buying up and spinning off companies since the ...

Baxter’s plant in North Carolina produces ... according to the FDA. Saline solution has been in short supply since 2018, sterile water since 2021, and dextrose solution since early 2022.

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

“Baxter just reported over the weekend that they were able to get approval from the FDA to import foreign-made saline solution,” said Ghilarducci. When asked about the safety of foreign supply ...

A shortage of intravenous (IV) saline fluids due to Hurricane Helene is forcing hospitals to defer non-urgent surgeries, and could hurt companies that make medical devices for elective procedures if ...

Like health care organizations across the country, AMED is dealing with a shortage of saline IV solution caused by damage to a Baxter International plant in Marion, N.C., from Hurricane Helene.

Medical device maker Baxter International said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by ...